Want to see CHE full AI Analyst Report?
CHE Stock Chart & Stats
$548.56
$8.12(1.61%)
At close: 4:00 PM EDT
$548.56
$8.12(1.61%)
Day’s Range― - ―
52-Week Range$365.21 - $557.00
Previous CloseN/A
Volume113.91K
Average Volume (3M)163.09K
Market Cap
$6.85B
Enterprise Value$6.44K
Total Cash (Recent Filing)$40.22M
Total Debt (Recent Filing)$329.09M
Price to Earnings (P/E)26.1
Beta0.32
Next Earnings
Nov 03, 2026EPS Estimate
6.48Next Dividend Ex-DateN/A
Dividend Yield0.48%
Share Statistics
EPS (TTM)19.92
Shares Outstanding13,069,961
10 Day Avg. Volume152,536
30 Day Avg. Volume163,095
Financial Highlights & Ratios
PEG Ratio-2.78
Price to Book (P/B)6.29
Price to Sales (P/S)2.43
P/FCF Ratio18.93
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$569.00Price Target Upside3.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)24.34
Revenue Forecast (FY)$2.69B
Bulls Say, Bears Say
Bulls Say
VITAS Growth And GuidanceVITAS is expanding patient volume and census while management raises growth expectations. Sustained admissions and ADC gains can improve operating leverage and reinforce the hospice segment’s contribution to consolidated earnings.
Strong Cash GenerationOperating cash flow exceeds reported net income and free cash flow remains substantial, indicating strong earnings quality. This internally generated liquidity supports acquisitions, share repurchases and ongoing investment without relying heavily on external financing.
Roto-Rooter Commercial ExpansionThe commercial-manager model is producing materially stronger growth than branches without managers, suggesting a scalable execution advantage. Franchise acquisitions and broader commercial penetration could diversify demand beyond residential service calls over time.
Bears Say
Margin And Cash Flow PressureAlthough absolute profitability and cash generation remain healthy, weaker incremental free cash flow, lower margins and higher leverage indicate reduced financial momentum. If sustained, these pressures could constrain flexibility and make growth more dependent on execution.
Roto-Rooter Operating HeadwindsRoto-Rooter is needing more paid marketing to generate demand while water restoration remains disrupted by centralization. Persistent acquisition costs and weaker restoration economics could limit segment margins and offset commercial growth.
VITAS Regulatory And Mix RiskGreater hospice oversight may increase compliance costs, slow expansion or affect reimbursement practices. Separately, shorter stays and unfavorable acuity mix can reduce per-patient economics, creating lasting risk to VITAS growth and margins.
Chemed News
CHE FAQ
What was Chemed Corporation’s price range in the past 12 months?
Chemed Corporation lowest stock price was $365.20 and its highest was $557.00 in the past 12 months.
What is Chemed Corporation’s market cap?
Chemed Corporation’s market cap is $6.85B.
When is Chemed Corporation’s upcoming earnings report date?
Chemed Corporation’s upcoming earnings report date is Nov 03, 2026 which is in 59 days.
How were Chemed Corporation’s earnings last quarter?
Chemed Corporation released its earnings results on Jul 28, 2026. The company reported $6.06 earnings per share for the quarter, beating the consensus estimate of $5.6 by $0.46.
Is Chemed Corporation overvalued?
According to Wall Street analysts Chemed Corporation’s price is currently Undervalued.
Does Chemed Corporation pay dividends?
Chemed Corporation pays a Quarterly dividend of $0.7 which represents an annual dividend yield of 0.48%. See more information on Chemed Corporation dividends here
What is Chemed Corporation’s EPS estimate?
Chemed Corporation’s EPS estimate is 6.48.
How many shares outstanding does Chemed Corporation have?
Chemed Corporation has 13,069,961 shares outstanding.
What happened to Chemed Corporation’s price movement after its last earnings report?
Chemed Corporation reported an EPS of $6.06 in its last earnings report, beating expectations of $5.6. Following the earnings report the stock price went up 4.198%.
Which hedge fund is a major shareholder of Chemed Corporation?
Currently, no hedge funds are holding shares in CHE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chemed Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$569.00 (3.73% Upside)
$569.00 (3.73% Upside)
Blogger Sentiment
Bullish
CHE Sentiment 75%
Sector Average 60%
Sector Average 60%
Hedge Fund Trend
Increased
By 42.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 1.9%
Last 30 Days ▲ 1.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
13.68%
12-Months-Change
Fundamentals
Return on Equity
0.48%
Trailing 12-Months
Asset Growth
-8.05%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Chemed Corporation
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
CHE Company Deck
CHE Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was decidedly positive: VITAS delivered strong top-line and profitability beats, materially improved Medicare cap positioning, and management raised full-year guidance across ADC, revenue and EBITDA margin while consolidated cash generation exceeded expectations. Roto-Rooter showed commercial momentum, margin recovery in gross profit, and strategic franchise buybacks, but faces persistent lead-generation/marketing cost pressure, water restoration transitional issues and modest margin drag. Regulatory oversight and mix/length-of-stay dynamics at VITAS are noted risks but were framed as managed and not materially impairing guidance.View all CHE earnings summariesCHE Stock 12 Month Forecast
Average Price Target
$569.00
▲(3.73% Upside)
Technical Analysis
Addus Homecare
―
Brookdale Senior Living
―
National Healthcare
―
Pennant Group
―
Aveanna Healthcare Holdings
―
Ownership Overview
1.12% Insiders
31.26% Mutual Funds
22.45% Other Institutional Investors
14.84% Public Companies and
Individual Investors